Main Article Content
Dr. Jeffrey Weitz, hematology, thromboembolism, interview, Canada Research Chair, cardiovascular
Currently the Heart and Stroke Foundation Endowed Chair in Cardiovascular Research and a Professor of Medicine and Biochemistry at McMaster University, the Canada Research Chair (Tier 1) in Thrombosis, and the Executive Director of the Thrombosis and Atherosclerosis Research Institute, Dr. Jeffrey Weitz is a highly-accomplished scholar in the field of hematology and thromboembolism. His research primarily focuses on the biochemistry of blood coagulation and fibrinolysis as they relate to venous and arterial thrombosis. Dr. Weitzs work on the thrombin-fibrin interaction and tissue-type plasminogen activator has been instrumental in opening up new avenues of exploration and has encouraged the development and clinical use of novel drugs. He received a Career Investigator Award and Distinguished Scientist Award from the Heart and Stroke Foundation, the Medal in Medicine from the Royal College of Physicians and Surgeons of Canada, and Research Achievement Awards from the Canadian Cardiovascular Society and the American Heart Association, as well as other honors in recognition of his contributions to the field. Dr. Weitz active involvement in clinical trials focuses on prophylaxis, diagnosis and treatment of clotting disorders and his ongoing dedication to medical education makes him a prominent figure in the field. This interview explores the field of hematology and thromboembolism. In particular, it focuses on the scope of Dr. Weitz work and gains his perspectives on research and medical education.